This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ecancer
G

ESMO 2024 Insights: Canadian Cancer Trials Group BR.31 Study - Adjuvant Durvalumab After Complete Tumor Resection & Optional Chemo in Early Stage (IB-IIIA) NSCLC

By ecancer FEATURING Glenwood Goss
By ecancer FEATURING Glenwood Goss
24 views
October 11, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

2024 ESMO Annual Meeting Insights Hub: Lung Videos

19:15

ESMO 2024 Summary: EGFRm NSCLC Panel Discussion - MARIPOSA, PAPILLON…

ecancer

I. Gil-Bazo, M. Brandão, B. Besse, E. Felip

220 views
18:01

ESMO 2024 Summary: Discussing Key Studies on the Use of Zipalertinib…

2024 ESMO Annual Meeting Insights Hub

J. Langen

75 views
11:54

ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients…

2024 ESMO Annual Meeting Insights Hub

R. Van den Begin

337 views
View All

Recommended

08:49

The Use of IO Doublet in PD-L1-Negative NSCLC

David Carbone

2.6K views
17:20

2024 Intervention Selection & Sequencing in Early Stage NSCLC

Total Health

J. Porter

1.3K views
35:40

Year in Review: Lung Cancer

Balazs Halmos

2.6K views
36:14

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

2024 ASCO® Annual Meeting Insights Hub

B. Halmos

811 views
18:47

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Total Health

W. Iams

6.4K views
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views
17:05

Mediastinal Staging of Lung Cancer

MI&T Congressi

R. Trisolini

476 views
26:38

Metastatic EGFRm NSCLC: 1L Therapy Options

University of Colorado Cancer Center

T. Patil

352 views
11:07

ASCO® 2023 Insights: "ADAURA Trial Key Learnings & Clinical Implicat…

Insights from 2023 ASCO® Annual Meeting

J. West

2.3K views
17:34

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

ecancer

L. Raez

909 views
16:12

2024 Updates on the Fast-Changing NSCLC Landscape

Total Health

R. Osarogiagbon

447 views
19:33

ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC

ecancer

E. Felip, A. Spira, A. Passaro, A. Addeo

499 views
21:50

Multidisciplinary Panel Discussion: New Treatment Options for Surgic…

David Carbone

B. Stiles

264 views
14:49

Year in Review: Precision Medicine

Vivek Subbiah

948 views
09:37

Controversies in NSCLC: Neoadjuvant vs. Adjuvant IO in Early Stage D…

Luis Raez

468 views
13:19

Duration of Immunotherapy Beyond 2 Years for Patients With Advanced …

IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

E. Rodriguez

2.1K views
28:32

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

413 views
11:45

ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in …

2024 ASCO® Annual Meeting Insights Hub

T. Mok

444 views
19:15

ESMO 2024 Summary: EGFRm NSCLC Panel Discussion - MARIPOSA, PAPILLON…

ecancer

I. Gil-Bazo, M. Brandão, B. Besse, E. Felip

220 views
14:17

WCLC 2024 Insights: Adjuvant vs. Neoadjuvant vs. Peri-Operative Ther…

Insights from 2024 WCLC

J. Von Der Thusen

179 views
AUTOPLAY